Galectin Therapeutics | GALT - 营业利润





营业利润 更改 日
AbbVie USD 4.73B 1.08B 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Galectin Therapeutics USD -11.29M 1.64M 2024-06
Gilead Sciences USD 2.68B 284M 2026-03
Immunic USD -23.33M 2.67M 2025-12
Incyte USD 324.17M 59.7M 2026-03
Merck USD -1.88B 8.12B 2026-03